Negotiable: Paramount Recruitment: Rare Disease Analyst - Permanent 100,000 Genomes Project - Bioinformatics - Central London Paramount are working in partnership with Genomics England to expand their team in order to deliver success with the 100,000 Genomes Project. London, England

Funding Opportunity RFA-MH-19-411 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits research grant applications which will: 1) advance measurements of intersectional stigma (multiple stigmatized identities) and examine the mechanisms and pathways by which it is a barrier to HIV testing and linkage to prevention; or 2) develop and test interventions to reduce intersectional stigma and improve the uptake of HIV testing and linkage to ongoing HIV prevention among key populations at substantial risk for HIV infection. RFA-MH-19-412 uses the R01 grant mechanism, and RFA-MH-19-410 uses the R34 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism. Applicants with preliminary data and/or include longitudinal analysis may be appropriate for the R01 mechanism. Applicants proposing to develop and pilot test an intervention should consider using the R34 mechanism.

Funding Opportunity RFA-MH-19-410 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits research grant applications which will: 1) advance measurements of intersectional stigma (multiple stigmatized identities) and examine the mechanisms and pathways by which it is a barrier to HIV testing and linkage to prevention; or 2) develop and test interventions to reduce intersectional stigma and improve the uptake of HIV testing and linkage to ongoing HIV prevention among key populations at substantial risk for HIV infection.

Funding Opportunity RFA-MH-19-412 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits research grant applications which will: 1) advance measurements of intersectional stigma (multiple stigmatized identities) and examine the mechanisms and pathways by which it is a barrier to HIV testing and linkage to prevention; or 2) develop and test interventions to reduce intersectional stigma and improve the uptake of HIV testing and linkage to ongoing HIV prevention among key populations at substantial risk for HIV infection.

Notice NOT-NS-19-024 from the NIH Guide for Grants and Contracts

Notice NOT-DK-19-004 from the NIH Guide for Grants and Contracts

Notice NOT-MH-19-004 from the NIH Guide for Grants and Contracts

Knowledge of bioinformatics is preferred. Hands-on experience on cell culture, flow cytometry, sub-cloning, qRT-PCR, ELISA and Western blot analysis....
From Society of Academic Associations of Anesthesiology and Perioperative Medicine (SAAAPM) - Wed, 21 Nov 2018 17:07:33 GMT - View all Milwaukee, WI jobs

Notice NOT-CA-19-013 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Director of Computational Biology, Cancer Immunology - Connecticut, United States Pharmaceutical, Translational Bioinformatics, Drug Discovery, Bioi Connecticut, USA

Notice NOT-OD-19-035 from the NIH Guide for Grants and Contracts

Serve as a technical expert for genomic sequencing and analysis within the Communicable Disease Division (CDD)....
From University of Wisconsin–Madison - Tue, 20 Nov 2018 18:57:33 GMT - View all Madison, WI jobs

Funding Opportunity RFA-AI-18-057 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate development of safe and effective long-acting drug delivery systems (LA-DDS) for improved, simplified treatment of HIV-1 in children. This FOA invites applicants engaged in the development of existing LA-DDS platforms at early product development stages to perform specific preclinical activities that enable product optimization and accelerated translation to HIV-1 infected children. Collaborative research partnerships with industry are required.

Notice NOT-CA-19-012 from the NIH Guide for Grants and Contracts

Notice NOT-AG-18-046 from the NIH Guide for Grants and Contracts

Notice NOT-AG-18-047 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-19-074 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research that examines the role of telomeres in wellness and disease, and to advance the incorporation of telomere studies into biobehavioral programs of research. A body of research has demonstrated the contribution of telomeres to health-related outcomes; however, additional studies are needed to achieve the full potential for incorporating telomere-guided approaches for maintaining wellness, reducing the risk and burden of disease, and for advancing symptom and self-management strategies.

Funding Opportunity PA-19-073 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research that examines the role of telomeres in wellness and disease, and to advance the incorporation of telomere studies into biobehavioral programs of research. A body of research has demonstrated the contribution of telomeres to health-related outcomes; however, additional studies are needed to achieve the full potential for incorporating telomere-guided approaches for maintaining wellness, reducing the risk and burden of disease, and for advancing symptom and self-management strategies.

Experience with computational biology or statistical bioinformatics is highly preferred. Familiarity with Genotyping by Sequencing (GBS) especially the library...
From Lancaster Laboratories - Tue, 20 Nov 2018 16:38:45 GMT - View all River Falls, WI jobs

Notice NOT-OD-19-033 from the NIH Guide for Grants and Contracts